Moderna Inc (NASDAQ:MRNA)
| 324.04 Delayed Data As of Oct 15 |  -7.84 / -2.36%Today’s Change | 65.49 Today|||52-Week Range 497.49 | +210.18% Year-to-Date |
Latest MRNA News | Press Releases
Today’s Trading
| Previous close | 331.88 |
| Today’s open | 340.76 |
| Day’s range | 318.51 - 341.50 |
| Volume | 517,616 |
| Average volume (3 months) | 16,492,658 |
| Market cap | $123.1B |
Data as of 5:53pm ET, 10/15/2021
Growth & Valuation
| Earnings growth (last year) | -26.08% |
| Earnings growth (this year) | +1,618.25% |
| Earnings growth (next 5 years) | -22.63% |
| Revenue growth (last year) | +1,234.34% |
| P/E ratio | 40.5 |
| Price/Sales | 49.59 |
| Price/Book | 47.47 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AMGNAmgen | +0.96 | +0.46% |
| GILDGilead Sciences | -0.52 | -0.76% |
| ILMNIllumina Inc | +1.66 | +0.41% |
| BIIBBiogen | -4.07 | -1.43% |
Data as of 4:12pm ET, 10/15/2021
Financials
| Next reporting date | November 4, 2021 |
| EPS forecast (this quarter) | $9.13 |
| Annual revenue (last year) | $803.4M |
| Annual profit (last year) | -$747.1M |
| Net profit margin | -92.99% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
